Serotonylation of Small GTPases Is a Signal Transduction Pathway that Triggers Platelet α-Granule Release

Cell

Volumn 115, Issue 7, 2003, Pages 851-862

  Walther, Diego J ^a   Peter, Jens Uwe ^a   Winter, Sandra ^b   Höltje, Markus ^b   Paulmann, Nils ^a   Grohmann, Maik ^a   Vowinckel, Jakob ^a   Alamo Bethencourt, Victor ^a   Wilhelm, Claudia S ^c   Ahnert Hilger, Gudrun ^b   Bader, Michael ^c  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN PLATELET ALPHA GRANULE; SEROTONIN; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RISK; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EXOCYTOSIS; EXPERIMENTAL MODEL; HEMOSTASIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; THROMBOSIS;

ANIMALIA;

EID: 9144236521     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)01014-6     Document Type: Article

References (51)

1. Aktories K., Schmidt G., Just I. Rho GTPases as targets of bacterial protein toxins. Biol. Chem. 381:2000;421-426.
2. Azim A.C., Barkalow K., Chou J., Hartwig J.H. Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor. Blood. 95:2000;959-964.
3. Azmitia E.C. Modern views on an ancient chemical. serotonin effects on cell proliferation, maturation, and apoptosis Brain Res. Bull. 56:2001;413-424.
4. Barradas M.A., Mikhailidis D.P., Dandona P. The effect of fenfluramine on collagen-induced platelet aggregation in vitro. Br. J. Clin. Pharmacol. 16:1983;459.
5. Bodie S.L., Ford I., Greaves M., Nixon G.F. Thrombin-induced activation of RhoA in platelet shape change. Biochem. Biophys. Res. Commun. 287:2001;71-76.
6. Buczko W., de Gaetano G., Garratini S. Efect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets. Br. J. Pharmacol. 53:1975;563-568.
7. Case A., Stein R.L. Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates. Biochemistry. 42:2003;9466-9481.
8. h during murine neuromuscular development. gene and enzyme isoform expression Neurochem. Int. 37:2000;337-349.
9. Cohen R.A., Shepherd J.T., Vanhoutte P.M. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science. 221:1983;273-274.
10. Dale G.L., Friese P., Batar P., Hamilton S.F., Reed G.L., Jackson K.W., Clemetson K.J., Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 415:2002;175-179.
11. De Clerk F., Somers Y., Van Gorp L. Platelet-vessel wall interactions in hemostasis. implication of 5-hydroxytryptamine Agents Actions. 15:1984;627-635.
12. Denis C., Methia N., Frenette P.S., Rayburn H., Ullman-Cullere M., Hynes R.O., Wagner D.D. A mouse model of severe von Willebrand disease. defects in hemostasis and thrombosis Proc. Natl. Acad. Sci. USA. 95:1998;9524-9529.
13. Doye A., Mettouchi A., Bossis G., Clément R., Buisson-Touati C., Flatau G., Gagnoux L., Piechaczyk M., Boquet P., Lemichez E. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell. 111:2002;553-564.
14. Eddahibi S., Humbert M., Fadel E., Raffestin B., Darmon M., Capron F., Simonneau G., Dartevelle P., Hamon M., Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J. Clin. Invest. 108:2001;1141-1150.
15. Eddahibi S., Raffestin B., Hamon M., Adnot S. Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension? J. Lab. Clin. Med. 139:2002;194-201.
16. Greenberg C.S., Birckbichler P.J., Rice R.H. Transglutaminases. multifunctional cross-linking enzymes that stabilize tissues FASEB J. 5:1991;3071-3077.
17. Griffin M., Casadio R., Bergamini C.M. Transglutaminases. nature's biological glues Biochem. J. 368:2002;377-396.
18. Höltje M., Winter S., Walther D.J., Pahner I., Hörtnagl H., Ottersen O.P., Bader M., Ahnert-Hilger G. The vesicular monoamine content regulates VMAT2 activity through Galphaq in mouse platelets. evidence for autoregulation of vesicular transmitter uptake J. Biol. Chem. 278:2003;15850-15858.
19. Holland J.M. Serotonin deficiency and prolonged bleeding in beige mice. Proc. Soc. Exp. Biol. Med. 151:1976;32-39.
20. Jackson S.P., Nesbitt W.S., Kulkarni S. Signaling events underlying thrombus formation. J. Thromb. Haemost. 1:2003;1602-1612.
21. Katayama T., Ikeda Y., Handa M., Tamatani T., Sakamoto S., Ito M., Ishimura Y., Suematsu M. Immunoneutralization of glycoprotein Ibα attenuates endotoxin-induced interactions of platelets and leukocytes with rat venular endothelium in vivo. Circ. Res. 86:2000;1031-1037.
22. Killam A.L., Cohen M.L. Characterization of rat platelet serotonin receptors with tryptamine agonists and the antagonists. ketanserin and SCH 23390 Thromb. Res. 64:1991;331-339.
23. Lee S.K., Chi J.G., Park S.C., Chung S.I. Transient expression of transglutaminase C during prenatal development of human muscles. J. Histochem. Cytochem. 48:2000;1565-1574.
24. Lesch K.-P., Wolozin B.L., Murphy D.L., Riederer P. Primary structure of the human platelet serotonin uptake site. identity with the brain serotonin transporter J. Neurochem. 60:1993;2319-2322.
25. 2A-adrenoceptor mediates decleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro. Platelets. 12:2001;359-375. a.
26. Maayani S., Tagliente T.M., Schwarz T., Craddock-Royal B., Alcala C., Marrero G., Martinez R. Deaggregation is an integral component of the response of platelets to ADP in vitro. kinetic studies of literature and original data Platelets. 12:2001;279-291. b.
27. Maggio N., Sellitti S., Capano C.P., Papa M. Tissue-transglutaminase in rat and human brain. light and electron immunocytochemical analysis and in situ hybridization study Brain Res. Bull. 56:2001;173-182.
28. Masuda M., Betancourt L., Matsuzawa T., Kashimoto T., Takao T., Shimonishi Y., Horiguchi Y. Activation of Rho through a cross-link with polyamines catalyzed by Bordetella dermonecrotizing toxin. EMBO J. 19:2000;521-530.
29. McNicol A., Israels S.J. Platelet dense granules. structure, function and implications for haemostasis Thromb. Res. 95:1999;1-18.
30. Melino G., Annicchiarico-Petruzzelli M., Piredda L., Candi E., Gentile V., Davies P.J., Piacentini M. Tissue transglutaminase and apoptosis. sense and antisense transfection studies with human neuroblastoma cells Mol. Cell. Biol. 14:1994;6584-6596.
31. Mohammad S.F., Reddick R.L., Mason R.G. Characterization of human platelets separated from blood by ADP-induced aggregation. Am. J. Pathol. 79:1975;81-91.
32. Ni H., Denis C.V., Subbarao S., Degen J.L., Sato T.N., Hynes R.O., Wagner D.D. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J. Clin. Invest. 106:2000;385-392.
33. Nishioka H., Horiuchi H., Tabuchi A., Yoshioka A., Shirakawa R., Kita T. Small GTPase Rho regulates thrombin-induced platelet aggregation. Biochem. Biophys. Res. Commun. 280:2001;970-975.
34. Offermanns S., Toombs C.F., Hu Y.H., Simon M.I. Defective platelet activation in G alpha(q)-deficient mice. Nature. 389:1997;183-186.
35. Palmer D.S., Aye M.T., Ganz P.R., Halpenny M., Hashemi S. Adenosine nucleotides and serotonin stimulate von Willebrand factor release from cultured human endothelial cells. Thromb. Haemost. 72:1994;132-139.
36. Puszkin E.G., Raghumaran V. Catalytic properties of a calmodulin-regulated transglutaminase from human platelet and chicken gizzard. J. Biol. Chem. 260:1985;16012-16020.
37. Rapport M.M., Green A.A., Page I.H. Cristalline Serotonin. Science. 108:1948;329-330.
38. Schlüter T., Bohnensack R. Serotonin-induced secretion of von Willebrand factor from human umbilical vein endothelial cells via the cyclic AMP-signalling system independent of increased cytoplasmic calcium concentration. Biochem. Pharmacol. 57:1999;1191-1197.
39. Schmidt G., Sehr P., Wilm M., Selzer J., Mann M., Aktories K. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature. 387:1997;725-729.
40. Schmidt G., Goehring U.-M., Schirmer J., Lerm M., Aktories K. Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for Rho GTPases. J. Biol. Chem. 274:1999;31875-31881.
41. 3 adhesion contacts under high shear. J. Biol. Chem. 277:2002;14738-14746.
42. Serafeim A., Grafton G., Chamba A., Gregory C.D., Blakely R.D., Bowery N.G., Barnes N.M., Gordon J. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells. reversal by selective serotonin reuptake inhibitors Blood. 99:2002;2545-2553.
43. Serebruany V.L., Gurbel P.A., O'Connor C.M. Platelet inhibition by sertraline and N-desmethylsertraline. a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors Pharmacol. Res. 43:2001;453-461.
44. 2+-induced α-granule secretion in platelets. J. Biol. Chem. 275:2000;33844-33849.
45. Siess W. Molecular mechanisms of platelet activation. Physiol. Rev. 69:1989;59-178.
46. Singh U.S., Kunar M.T., Kao Y.-L., Baker K.M. Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. EMBO J. 20:2001;2413-2423.
47. Singh U.S., Pan J., Kao Y.L., Joshi S., Young K.L., Baker K.M. Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Biol. Chem. 278:2003;391-399.
48. Szasz R., Dale G.L. Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets. Blood. 100:2002;2827-2831.
49. Tucholski J., Lesort M., Johnson G.V.W. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience. 102:2001;481-491.
50. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Voits M., Fink H., Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 299:2003;76.
51. Walther D.J., Bader M. Serotonin synthesis in murine embryonic stem cells. Brain Res. Mol. Brain Res. 68:1999;55-63.